{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:45:10Z","timestamp":1780479910474,"version":"3.54.1"},"reference-count":116,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, the prevalence of infertility has increased, and appears to affect approximately one in six couples. Some of them must perform assisted reproductive techniques (ART) in order to achieve pregnancy. As a result, growing interest has arisen about predictive factors of pregnancy and live birth with and without ART. Anti-Mullerian hormone (AMH) is a glycoprotein discovered in the 1950s in male embryonic sexual differentiation. Later, in 1984, its role in folliculogenesis was reported: secreted by granulosa cells, this hormone is involved in the regulation of the recruitment of primordial follicles and in follicular growth. AMH assays were developed for women in 1990s, and the serum AMH level has rapidly become a crucial element in managing women's fertility. Based mainly on its ability to be a quantitative but indirect marker of ovarian reserve, the serum AMH assay is widely used in reproductive medicine and ART. This review summarizes current knowledge of the AMH assessment in the field of reproductive medicine. We focus on the role of AMH level to predict spontaneous pregnancy occurrence, ART outcomes, and fertility preservation outcomes.<\/jats:p>","DOI":"10.1055\/s-0044-1787273","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T22:33:31Z","timestamp":1721342011000},"page":"025-033","source":"Crossref","is-referenced-by-count":9,"title":["Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception"],"prefix":"10.1055","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-6693","authenticated-orcid":false,"given":"In\u00e8s","family":"Sellami","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine de la Reproduction et Pr\u00e9servation de la Fertilit\u00e9, APHP-Universit\u00e9 Paris-Saclay, H\u00f4pital Antoine B\u00e9cl\u00e8re, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-6061","authenticated-orcid":false,"given":"Anne Laure","family":"Barbotin","sequence":"additional","affiliation":[{"name":"CHU Lille, Service de Biologie de la Reproduction, Universit\u00e9 de Lille, H\u00f4pital Jeanne de Flandre, Lille, France"},{"name":"CHU Lille, Facult\u00e9 de M\u00e9decine Henri Warembourg, Universit\u00e9 de Lille, Lille Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2898-0381","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Bernard","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie et M\u00e9decine de la Reproduction, Centre Ali\u00e9nor d'Aquitaine, Bordeaux University Hospital, Bordeaux, France"},{"name":"University Bordeaux, Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3185","authenticated-orcid":false,"given":"Geoffroy","family":"Robin","sequence":"additional","affiliation":[{"name":"CHU Lille, Facult\u00e9 de M\u00e9decine Henri Warembourg, Universit\u00e9 de Lille, Lille Cedex, France"},{"name":"CHU Lille, Service Assistance M\u00e9dicale \u00e0 la Procr\u00e9ation et Pr\u00e9servation de la Fertilit\u00e9 - Service de Gyn\u00e9cologie M\u00e9dicale, Orthog\u00e9nie et Sexologie, H\u00f4pital Jeanne de Flandre, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Catteau-Jonard","sequence":"additional","affiliation":[{"name":"CHU Lille, Facult\u00e9 de M\u00e9decine Henri Warembourg, Universit\u00e9 de Lille, Lille Cedex, France"},{"name":"CHU Lille, Service Assistance M\u00e9dicale \u00e0 la Procr\u00e9ation et Pr\u00e9servation de la Fertilit\u00e9 - Service de Gyn\u00e9cologie M\u00e9dicale, Orthog\u00e9nie et Sexologie, H\u00f4pital Jeanne de Flandre, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-1592","authenticated-orcid":false,"given":"Charlotte","family":"Sonigo","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine de la Reproduction et Pr\u00e9servation de la Fertilit\u00e9, APHP-Universit\u00e9 Paris-Saclay, H\u00f4pital Antoine B\u00e9cl\u00e8re, Clamart, France"},{"name":"Universit\u00e9 Paris Saclay, Inserm, Physiologie et Physiopathologie Endocrinienne, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-0740","authenticated-orcid":false,"given":"Maeliss","family":"Peign\u00e9","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine de la Reproduction et Pr\u00e9servation de la Fertilit\u00e9, AP-HP-Universit\u00e9 Sorbonne Paris Nord, H\u00f4pital Jean Verdier, Bondy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"R Fleming","year":"2015","journal-title":"Reprod Biomed Online"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"D Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"H J Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2016-3799","article-title":"Anti-M\u00fcllerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism\/Kallmann syndrome: effects of recombinant human FSH","volume":"102","author":"H Bry-Gauillard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.fertnstert.2012.08.008","article-title":"Low concentration of circulating antiM\u00fcllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study","volume":"98","author":"C P Hagen","year":"2012","journal-title":"Fertil Steril"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2015-2474","article-title":"Is anti-M\u00fcllerian hormone associated with fecundability? findings from the EAGeR trial","volume":"100","author":"S M Zarek","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2013.10.007","article-title":"AMH concentration is not related to effective time to pregnancy in women who conceive naturally","volume":"28","author":"I Streuli","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/09513590.2017.1306848","article-title":"Anti-M\u00fcllerian hormone does not predict time to pregnancy: results of a prospective cohort study","volume":"33","author":"M Depmann","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"A Z Steiner","year":"2017","journal-title":"JAMA"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5653\/cerm.2018.45.1.31","article-title":"The likelihood of achieving pregnancy through timed coitus in young infertile women with decreased ovarian reserve","volume":"45","author":"H S Koo","year":"2018","journal-title":"Clin Exp Reprod Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-11-61","article-title":"Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility","volume":"11","author":"T Murto","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.fertnstert.2013.05.009","article-title":"Antim\u00fcllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study","volume":"100","author":"F Yarde","year":"2013","journal-title":"Fertil Steril"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/09513590.2018.1465548","article-title":"Anti-M\u00fcllerian hormone levels and spontaneous pregnancy in women undergoing surgery for benign ovarian cysts","volume":"34","author":"L Casadei","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.fertnstert.2016.12.013","article-title":"Does preoperative antim\u00fcllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?","volume":"107","author":"E Stochino-Loi","year":"2017","journal-title":"Fertil Steril"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2022.10.014","article-title":"Markers of ovarian reserve as predictors of future fertility","volume":"119","author":"B S Harris","year":"2023","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40738-019-0054-z","article-title":"Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss","volume":"5","author":"G Murugappan","year":"2019","journal-title":"Fertil Res Pract"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-018-4946-7","article-title":"Does anti-Mullerian hormone predict the outcome of further pregnancies in idiopathic recurrent miscarriage? A retrospective cohort study","volume":"299","author":"S Pils","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI","year":"2016","journal-title":"Hum Reprod"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","article-title":"Role of anti-M\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review","volume":"13","author":"A Dumont","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10815-021-02217-x","article-title":"Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-M\u00fcllerian hormone levels","volume":"38","author":"S Vagios","year":"2021","journal-title":"J Assist Reprod Genet"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.fertnstert.2023.12.031","article-title":"Antim\u00fcllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin","volume":"121","author":"A S Komorowski","year":"2024","journal-title":"Fertil Steril"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/humrep\/dep271","article-title":"The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy","volume":"24","author":"S A Amer","year":"2009","journal-title":"Hum Reprod"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/09513590.2018.1499085","article-title":"The role of anti-M\u00fcllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome","volume":"35","author":"M S G\u00fcl\u015fen","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5653\/cerm.2016.43.4.207","article-title":"Anti-M\u00fcllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate","volume":"43","author":"A Hestiantoro","year":"2016","journal-title":"Clin Exp Reprod Med"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-M\u00fcllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study","volume":"98","author":"A Mahran","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13048-016-0214-2","article-title":"Circulating anti-Mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome","volume":"9","author":"W Xi","year":"2016","journal-title":"J Ovarian Res"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/09513590.2015.1110138","article-title":"Limited ability of circulating anti-M\u00fcllerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays","volume":"32","author":"A Vaiarelli","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.fertnstert.2015.12.023","article-title":"Comparative assessment of five serum antim\u00fcllerian hormone assays for the diagnosis of polycystic ovary syndrome","volume":"105","author":"P Pigny","year":"2016","journal-title":"Fertil Steril"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2020.07.023","article-title":"A patient-specific model combining antim\u00fcllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders","volume":"115","author":"S Vagios","year":"2021","journal-title":"Fertil Steril"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3390\/jcm12154943","article-title":"How to choose the optimal starting dose of clomiphene citrate (50 or 100\u2009mg per day) for a first cycle of ovulation induction in anovulatory PCOS women?","volume":"12","author":"L Huyghe","year":"2023","journal-title":"J Clin Med"},{"issue":"04","key":"ref31","doi-asserted-by":"publisher","DOI":"10.22062\/jkmu.2020.91022","article-title":"Live birth rate following intrauterine insemination in women with low or very low level of serum anti-M\u00fcllerian hormone","volume":"27","author":"M Mehrafza","year":"2020","journal-title":"JKMU"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1016\/j.eurox.2019.100043","article-title":"Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination","volume":"3","author":"J Moreau","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2019.12.006","article-title":"Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve","volume":"113","author":"A W Tiegs","year":"2020","journal-title":"Fertil Steril"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1479-828X.2010.01232.x","article-title":"Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy","volume":"50","author":"K Tremellen","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"02","key":"ref35","first-page":"122","article-title":"[Intra-uterine insemination outcomes according to the serum AMH level on day 3]","volume":"41","author":"F Lamazou","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?","volume":"31","author":"P Bakas","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/JCMA.0000000000000023","article-title":"The role of anti-M\u00fcllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination","volume":"82","author":"B Seckin","year":"2019","journal-title":"J Chin Med Assoc"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.rbmo.2010.02.007","article-title":"Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study","volume":"20","author":"Nl Freiesleben","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"07","key":"ref39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/01443615.2013.810199","article-title":"Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds","volume":"33","author":"B E Speyer","year":"2013","journal-title":"J Obstet Gynaecol"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"H WR Li","year":"2010","journal-title":"Fertil Steril"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","article-title":"Anti-M\u00fcllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients","volume":"89","author":"E A Elgindy","year":"2008","journal-title":"Fertil Steril"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"A La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"S L Broer","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"J C Arce","year":"2013","journal-title":"Fertil Steril"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","article-title":"Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization","volume":"104","author":"O Hamdine","year":"2015","journal-title":"Fertil Steril"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2015.10.004","article-title":"Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antim\u00fcllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"105","author":"D B Seifer","year":"2016","journal-title":"Fertil Steril"},{"issue":"09","key":"ref47","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/clinem\/dgab168","article-title":"AMH highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age","volume":"106","author":"R Tal","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13048-023-01202-5","article-title":"Comparison of anti-M\u00fcllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis","volume":"16","author":"Y Liu","year":"2023","journal-title":"J Ovarian Res"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.rbmo.2020.12.001","article-title":"The risk of poor ovarian response during repeat IVF","volume":"42","author":"A Papathanasiou","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.ajog.2008.05.004","article-title":"Assessment of ovarian reserve with anti-M\u00fcllerian hormone: a comparison of the predictive value of anti-M\u00fcllerian hormone, follicle-stimulating hormone, inhibin B, and age","volume":"199","author":"R M Riggs","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"J Qiao","year":"2021","journal-title":"Hum Reprod"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.fertnstert.2020.10.059","article-title":"Randomized, assessor-blind, antim\u00fcllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta","volume":"115","author":"O Ishihara","year":"2021","journal-title":"Fertil Steril"},{"issue":"05","key":"ref53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.rbmo.2021.01.023","article-title":"Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial","volume":"42","author":"O Ishihara","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2017.01.012","article-title":"A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF\/ICSI cycles","volume":"34","author":"A Allegra","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"A Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jogoh.2017.08.001","article-title":"What are the likely IVF\/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study","volume":"46","author":"F Daney de Marcillac","year":"2017","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"S L Broer","year":"2013","journal-title":"Fertil Steril"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"S L Broer","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"08","key":"ref59","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/deab152","article-title":"Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients","volume":"36","author":"S C Esteves","year":"2021","journal-title":"Hum Reprod"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.rbmo.2018.12.032","article-title":"Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and\/or the need for additional preventive interventions: cumulative data over three stimulation cycles","volume":"38","author":"M Fern\u00e1ndez-S\u00e1nchez","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"01","key":"ref61","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"1","author":"O Ngwenya","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"08","key":"ref62","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"S J Morin","year":"2018","journal-title":"Hum Reprod"},{"issue":"06","key":"ref63","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.rbmo.2021.03.006","article-title":"Serum anti-M\u00fcllerian hormone levels are not associated with aneuploidy rates in human blastocysts","volume":"42","author":"A Pipari","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5468\/ogs.20168","article-title":"Association between decreased ovarian reserve and poor oocyte quality","volume":"64","author":"V M Scantamburlo","year":"2021","journal-title":"Obstet Gynecol Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"748447","DOI":"10.3389\/fimmu.2021.748447","article-title":"Interaction between chronic endometritis caused endometrial microbiota disorder and endometrial immune environment change in recurrent implantation failure","volume":"12","author":"P Chen","year":"2021","journal-title":"Front Immunol"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1038\/s41598-020-76543-y","article-title":"AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles","volume":"10","author":"X Dai","year":"2020","journal-title":"Sci Rep"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00404-015-3901-0","article-title":"The influence of AMH on IVF success","volume":"293","author":"R Gomez","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-M\u00fcllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"S Lie Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.rbmo.2021.01.001","article-title":"Euploidy rates of embryos in young patients with good and low prognosis according to the POSEIDON criteria","volume":"42","author":"G Karl\u0131kaya","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.rbmo.2018.04.039","article-title":"Low anti-M\u00fcllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age","volume":"37","author":"X Jiang","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"04","key":"ref71","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-M\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"S Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"R Tal","year":"2015","journal-title":"Fertil Steril"},{"issue":"09","key":"ref73","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/humrep\/dead147","article-title":"Using serum anti-M\u00fcllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis","volume":"38","author":"M Peign\u00e9","year":"2023","journal-title":"Hum Reprod"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"T Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fertnstert.2019.03.022","article-title":"Low antim\u00fcllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant","volume":"112","author":"S Ligon","year":"2019","journal-title":"Fertil Steril"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.fertnstert.2015.04.032","article-title":"Antim\u00fcllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth","volume":"104","author":"S M Nelson","year":"2015","journal-title":"Fertil Steril"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-6-3","article-title":"External validation of anti-M\u00fcllerian hormone based prediction of live birth in assisted conception","volume":"6","author":"A Khader","year":"2013","journal-title":"J Ovarian Res"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction","volume":"22","author":"A La Marca","year":"2011","journal-title":"Reprod Biomed Online"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2013.01.013","article-title":"Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization","volume":"168","author":"K Lukaszuk","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"03","key":"ref80","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","article-title":"Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology","volume":"14","author":"K Lukaszuk","year":"2014","journal-title":"Reprod Biol"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1479-828X.2011.01374.x","article-title":"Using anti-M\u00fcllerian hormone to identify a good prognosis group in women of advanced reproductive age","volume":"51","author":"B Frid\u00e9n","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1477-7827-7-100","article-title":"Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles","volume":"7","author":"T H Lee","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"ref83","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve","volume":"30","author":"Z Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","article-title":"Anti-M\u00fcllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-M\u00fcllerian hormone is modest","volume":"225","author":"S SE Alson","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejogrb.2020.06.063","article-title":"Ovarian reserve as a predictor of cumulative live birth","volume":"252","author":"N Balachandren","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12884-020-03446-1","article-title":"Anti-M\u00fcllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study","volume":"20","author":"K Ezoe","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","article-title":"Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome","volume":"17","author":"K Keane","year":"2017","journal-title":"Reprod Biol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2017.12.047","article-title":"Predictive value of antral follicle count and serum anti-M\u00fcllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?","volume":"221","author":"Y Lee","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"e61095","DOI":"10.1371\/journal.pone.0061095","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis","volume":"8","author":"H WR Li","year":"2013","journal-title":"PLoS One"},{"issue":"09","key":"ref90","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jog.14269","article-title":"Anti-M\u00fcllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4","volume":"46","author":"L Liu","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"09","key":"ref91","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy","volume":"22","author":"S M Nelson","year":"2007","journal-title":"Hum Reprod"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humrep\/deaa008","article-title":"Low anti-M\u00fcllerian hormone level is not a risk factor for early pregnancy loss in IVF\/ICSI treatment","volume":"35","author":"P Peuranp\u00e4\u00e4","year":"2020","journal-title":"Hum Reprod"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2016.02.007","article-title":"The value of anti-M\u00fcllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization","volume":"200","author":"I F Reijnders","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"06","key":"ref94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array CGH analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"B Ata","year":"2012","journal-title":"Reprod Biomed Online"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rbmo.2018.01.016","article-title":"Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls","volume":"36","author":"C Decanter","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"ref96","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and Onco-fertility preservation: factors related to IVF outcomes","volume":"33","author":"A Cobo","year":"2018","journal-title":"Hum Reprod"},{"issue":"04","key":"ref97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","article-title":"Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience","volume":"32","author":"E R Cardozo","year":"2015","journal-title":"J Assist Reprod Genet"},{"issue":"08","key":"ref98","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2217\/fon.14.76","article-title":"Anti-M\u00fcllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation","volume":"10","author":"R Fabbri","year":"2014","journal-title":"Future Oncol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fsurg.2017.00040","article-title":"Fertility preservation in endometriosis patients: anti-M\u00fcllerian hormone is a reliable marker of the ovarian follicle density","volume":"4","author":"E Garavaglia","year":"2017","journal-title":"Front Surg"},{"issue":"11","key":"ref100","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10815-021-02320-z","article-title":"Hormonal response in patients transplanted with cryopreserved ovarian tissue is independent of whether freezing was performed in childhood or adulthood","volume":"38","author":"V G Hornsh\u00f8j","year":"2021","journal-title":"J Assist Reprod Genet"},{"issue":"04","key":"ref101","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jc.2010-2188","article-title":"Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment","volume":"96","author":"F Janse","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"R A Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"issue":"04","key":"ref103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.xfnr.2022.07.002","article-title":"In vitro maturation of oocytes for fertility preservation: a comprehensive review","volume":"3","author":"M Grynberg","year":"2022","journal-title":"F&S Reviews"},{"issue":"04","key":"ref104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hon.2724","article-title":"In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions","volume":"38","author":"C Sonigo","year":"2020","journal-title":"Hematol Oncol"},{"issue":"07","key":"ref105","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/dew102","article-title":"What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?","volume":"31","author":"C Sonigo","year":"2016","journal-title":"Hum Reprod"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2478\/raon-2021-0053","article-title":"In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program","volume":"56","author":"I Virant-Klun","year":"2021","journal-title":"Radiol Oncol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-12-26","article-title":"Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review","volume":"12","author":"M Peign\u00e9","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.fertnstert.2013.03.014","article-title":"Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer","volume":"99","author":"R A Anderson","year":"2013","journal-title":"Fertil Steril"},{"issue":"03","key":"ref109","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/07357900701829777","article-title":"A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer","volume":"26","author":"C Anders","year":"2008","journal-title":"Cancer Invest"},{"issue":"12","key":"ref110","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.bjc.6603814","article-title":"Predictors of ovarian reserve in young women with breast cancer","volume":"96","author":"K Lutchman Singh","year":"2007","journal-title":"Br J Cancer"},{"issue":"05","key":"ref111","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rbmo.2014.07.008","article-title":"Ovarian reserve in breast cancer: assessment with anti-M\u00fcllerian hormone","volume":"29","author":"A S Hamy","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rbmo.2015.12.008","article-title":"Anti-M\u00fcllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies","volume":"32","author":"A S Hamy","year":"2016","journal-title":"Reprod Biomed Online"},{"issue":"02","key":"ref113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-M\u00fcllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results","volume":"20","author":"C Decanter","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"06","key":"ref114","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1210\/jc.2011-3180","article-title":"Anti-M\u00fcllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study","volume":"97","author":"M FH Brougham","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humrep\/dex008","article-title":"Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients","volume":"32","author":"R H Goldman","year":"2017","journal-title":"Hum Reprod"},{"issue":"07","key":"ref116","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10815-020-01791-w","article-title":"Likelihood of achieving a 50%, 60%, or 70% estimated live birth rate threshold with 1 or 2 cycles of planned oocyte cryopreservation","volume":"37","author":"B L Maslow","year":"2020","journal-title":"J Assist Reprod Genet"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1787273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:43:32Z","timestamp":1730817812000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1787273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":116,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,7,18]]},"published-print":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1787273","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}